XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from Operating activities:              
Net loss $ (9,401) $ (12,689) $ (13,341) $ (7,873) $ (31,929) $ (31,046)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         2,698 1,627  
Allowance for credit losses         382 1,947  
Inventory impairment         267 346  
Share-based compensation         4,667 4,320  
Non-cash interest expense         600 580  
Loss on extinguishment of debt     4,427     4,427  
Loss on disposal of property and equipment         45    
Changes in certain assets and liabilities:              
Accounts receivable, net         1,384 (3,834)  
Inventory         (240) 2,718  
Net investments in sales-type leases         22 854  
Prepaid commission expense         840 (770)  
Prepaid expenses and other assets         3,813 (374)  
Accounts payable         (77) (1,524)  
Accrued expenses         (3,302) (1,166)  
Other liabilities         (223)    
Deferred revenue         (229) (506)  
Net Cash used in Operating activities         (21,282) (22,401) $ (31,000)
Cash flows from Investing activities:              
Purchases of property and equipment and capitalized software         (585) (1,377)  
Repayment of notes receivable           1,340  
Net Cash used in Investing activities         (585) (37)  
Cash flows from Financing activities:              
Payments of debt issuance costs         (80) (2,188)  
Proceeds from issuance of long-term debt         10,000 48,084  
Proceeds from issuance of warrants           1,916  
Repayment of long-term debt           (60,000)  
Payment for debt extinguishment cost           (4,185)  
Proceeds from exercises of stock options         13 1  
Net Cash provided by (used in) Financing activities         36,879 (16,372)  
Net increase (decrease) in Cash, Cash equivalents and Restricted cash         15,012 (38,810)  
Cash, Cash equivalents and Restricted cash, Beginning of Period   $ 19,459   $ 59,677 19,459 59,677 59,677
Cash, Cash equivalents and Restricted cash, End of Period 34,471   20,867   34,471 20,867 19,459
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:              
Cash and cash equivalents 27,971   20,867   27,971 20,867 18,459
Restricted cash and cash equivalents 6,500       6,500   1,000
Total cash, cash equivalents and restricted cash 34,471   $ 20,867   34,471 20,867 $ 19,459
Supplemental disclosure of cash flow information:              
Cash paid for interest         5,474 4,948  
Transfer of inventory to property and equipment         75 92  
Supplemental disclosure of non-cash investing and financing activities:              
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses         30 67  
Issuance costs associated with the ATM Program recorded to additional paid-in capital in accounts payable and accrued expenses         136    
Reduction of accounts receivable in current and long-term notes receivable           $ 606  
Secondary public offering              
Cash flows from Financing activities:              
Proceeds from the issuance of common stock         20,700    
Payments of common stock offering issuance costs         (1,731)    
ATM Program              
Cash flows from Financing activities:              
Proceeds from the issuance of common stock $ 8,300       8,313    
Payments of common stock offering issuance costs         $ (336)